Literature DB >> 9228859

Hearing loss (in nonoperated ears) in relation to age in osteogenesis imperfecta type I.

A J Garretsen1, C W Cremers, P L Huygén.   

Abstract

Hearing loss was studied in relation to age in nonoperated ears in a group of 142 subjects with autosomal dominant osteogenesis imperfecta type I, which was compared to that in a random subsample of 70 subjects. In the n = 142 group, particularly below the age of 30 years, considerable selection (ie, for ear surgery) had occurred on hearing loss. The hearing threshold increased gradually with age. A hearing loss of greater than 30 dB (Fletcher index) was observed for 51% of the subjects older than 20 years and younger than 60 years. The median hearing loss progressed from the 10th to the 45th years of life with an average annual threshold increase (ATI) of 1 dB/y (0.5 to 4 kHz) up to 1.7 dB/y (8 kHz). Sensorineural loss accounted for 0.6 dB/y ATI at 0.5 to 4 kHz and 1.3 dB/y ATI at 8 kHz; conductive loss accounted for 0.4 dB/y ATI at all frequencies.

Entities:  

Mesh:

Year:  1997        PMID: 9228859     DOI: 10.1177/000348949710600709

Source DB:  PubMed          Journal:  Ann Otol Rhinol Laryngol        ISSN: 0003-4894            Impact factor:   1.547


  9 in total

1.  Stapes surgery in osteogenesis imperfecta: retrospective analysis of 18 operated ears.

Authors:  M Hijazi; S D Mihailescu; J Horion; A Goldenberg; J P Marie
Journal:  Eur Arch Otorhinolaryngol       Date:  2021-01-12       Impact factor: 2.503

Review 2.  New perspectives on osteogenesis imperfecta.

Authors:  Antonella Forlino; Wayne A Cabral; Aileen M Barnes; Joan C Marini
Journal:  Nat Rev Endocrinol       Date:  2011-06-14       Impact factor: 43.330

3.  Osteogenesis imperfecta and hearing loss: an analysis of patients attended at a benchmark treatment center in southern Brazil.

Authors:  Andressa Colares da Costa Otavio; Adriane Ribeiro Teixeira; Temis Maria Félix; Letícia Petersen Schimidt Rosito; Sady Selaimen da Costa
Journal:  Eur Arch Otorhinolaryngol       Date:  2020-01-31       Impact factor: 2.503

Review 4.  Osteogenesis imperfecta: practical treatment guidelines.

Authors:  F Antoniazzi; M Mottes; P Fraschini; P C Brunelli; L Tatò
Journal:  Paediatr Drugs       Date:  2000 Nov-Dec       Impact factor: 3.022

Review 5.  Genetics of otosclerosis: finally catching up with other complex traits?

Authors:  Lisse J M Tavernier; Erik Fransen; Hanne Valgaeren; Guy Van Camp
Journal:  Hum Genet       Date:  2021-09-09       Impact factor: 4.132

6.  Osteogenesis Imperfecta: the audiological phenotype lacks correlation with the genotype.

Authors:  Freya K R Swinnen; Paul J Coucke; Anne M De Paepe; Sofie Symoens; Fransiska Malfait; Filomena V Gentile; Luca Sangiorgi; Patrizia D'Eufemia; Mauro Celli; Ton J T M Garretsen; Cor W R J Cremers; Ingeborg J M Dhooge; Els M R De Leenheer
Journal:  Orphanet J Rare Dis       Date:  2011-12-29       Impact factor: 4.123

7.  Treatments for hearing loss in osteogenesis imperfecta: a systematic review and meta-analysis on their efficacy.

Authors:  Maialen Ugarteburu; Luis Cardoso; Claus-Peter Richter; Alessandra Carriero
Journal:  Sci Rep       Date:  2022-10-12       Impact factor: 4.996

8.  Phenotypic variability of osteogenesis imperfecta type V caused by an IFITM5 mutation.

Authors:  Jay R Shapiro; Caressa Lietman; Monica Grover; James T Lu; Sandesh Cs Nagamani; Brian C Dawson; Dustin M Baldridge; Matthew N Bainbridge; Dan H Cohn; Maria Blazo; Timothy T Roberts; Feng-Shu Brennen; Yimei Wu; Richard A Gibbs; Pamela Melvin; Philippe M Campeau; Brendan H Lee
Journal:  J Bone Miner Res       Date:  2013-07       Impact factor: 6.741

9.  Hearing loss in osteogenesis imperfecta: characteristics and treatment considerations.

Authors:  Joseph P Pillion; David Vernick; Jay Shapiro
Journal:  Genet Res Int       Date:  2011-12-14
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.